Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 14, 2006

Adult Stem Cell Processing and Banking Facility Completed

  • Bio-Matrix Scientific Group completed the construction and installation of its new Stem Cell Class 10,000 processing laboratory. "The new class 10,000 laboratory is custom-built to the highest industry specifications,” explains Brian Pockett, managing director and COO. “We believe that we can begin the storage of specimens during the first quarter of 2007 after the installation and testing of all related necessary equipment."

    Bio-Matrix' new 15,000-sq-ft facility, located in the San Diego biotechnology corridor, will house the company's cryogenic stem cell bank, three research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, and hematology, microbiology, and flow cytometry laboratories.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »